Seizure Remission and Its Predictors Among Epileptic Patients on Follow-Up at Public Hospitals in Eastern Ethiopia: A Retrospective Cohort Study

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2023 Nov 29

PMID 38021051

Authors

Ammas Siraj Mohammed

Kirubel Minsamo Mishore

Tadesse Bekele Tafesse

Abera Jambo

Ahmed Mohammed Husen

Addisu Alemu

Affiliations

Soon will be listed here.

Abstract

Background: Epilepsy is one of the common chronic neurological disorders with varying therapeutic responses. Despite the high prevalence of epilepsy and the significant treatment gaps in developing nations, such as Ethiopia, there is a dearth of data on seizure remission and its predictors in Eastern Ethiopia in particular.

Objective: This study aimed to determine seizure remission and its predictors among epileptic patients on follow-up in Hiwot Fana Specialized University Hospital (HFSUH) and Dilchora Referral Hospital (DCRH), from July 2 to 31, 2021.

Methods: A retrospective cohort study was conducted among 418 newly diagnosed epilepsy patients receiving anti-seizure drugs (ASDs) between July 1, 2014, and July 31, 2019, in two public hospitals in Eastern Ethiopia. Relevant data were collected for all patients with a minimum follow-up period of two years. Data were analyzed using SPSS Version 21. Cox proportional hazards model was performed to identify predictors of seizure remission.

Results: Overall, 252 (60.3%) of the study participants have achieved seizure remission for at least one year. The mean time to achieve seizure remission was 1.9 ± 0.87 years. Regarding the seizure remission pattern, 171 (40.9%) patients achieved early remission, 81 (19.4%) achieved late remission, and 166 (39.7%) achieved no remission. Shorter pre-treatment duration (AHR = 2.36, 95% CI: 1.28-4.37); good adherence to ASDs (AHR = 2.40, 95% CI: 1.33-4.34); and monotherapy (AHR = 0.56, 95% CI: 0.32-0.98) were predictors of seizure remission.

Conclusion: We observed that less than two-thirds of epileptic patients had achieved seizure remission. A shorter pre-treatment duration, good adherence to ASDs, and monotherapy were predictors of seizure remission. Therefore, we recommend the requirement of an integrated effort from different health disciplines that increases patients' adherence to ASDs, promotes early visits to medical facilities, and improves the health-seeking behavior of epileptic patients.

Citing Articles

Incidence and predictors of seizure-related injuries among epileptic patients undergoing follow-up treatment at public hospitals in Central Ethiopia.

Begizew S, Muluneh B, Ashine T, Heliso A, Babore G, Ezo Ereta E Sci Rep. 2025; 15(1):3899.

PMID: 39890819 PMC: 11785985. DOI: 10.1038/s41598-025-86268-5.

References

Nevitt S, Sudell M, Weston J, Tudur Smith C, Marson A . Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2017; 12:CD011412. PMC: 6486134. DOI: 10.1002/14651858.CD011412.pub3. View

de Boer H, Mula M, Sander J . The global burden and stigma of epilepsy. Epilepsy Behav. 2008; 12(4):540-6. DOI: 10.1016/j.yebeh.2007.12.019. View

Beyene A, Ayalew A, Mulat G, Simachew Kassa A, Birhan T . The treatment outcomes of epilepsy and its root causes in children attending at the University of Gondar teaching hospital: A retrospective cohort study, 2018. PLoS One. 2020; 15(3):e0230187. PMC: 7067446. DOI: 10.1371/journal.pone.0230187. View

Sperling M . The consequences of uncontrolled epilepsy. CNS Spectr. 2004; 9(2):98-101, 106-9. DOI: 10.1017/s1092852900008464. View

Forsgren L, Ekstedt J . Incidence of epilepsy in rural central Ethiopia. Epilepsia. 1997; 38(5):541-6. DOI: 10.1111/j.1528-1157.1997.tb01138.x. View

Neligan A, Bell G, Johnson A, Goodridge D, Shorvon S, Sander J . The long-term risk of premature mortality in people with epilepsy. Brain. 2011; 134(Pt 2):388-95. DOI: 10.1093/brain/awq378. View

Rogawski M, Johnson M . Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr. 2008; 8(5):127-30. PMC: 2566613. DOI: 10.1111/j.1535-7511.2008.00272.x. View

Fisher R, Cross J, French J, Higurashi N, Hirsch E, Jansen F . Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4):522-530. DOI: 10.1111/epi.13670. View

Niriayo Y, Mamo A, Kassa T, Asgedom S, Atey T, Gidey K . Treatment outcome and associated factors among patients with epilepsy. Sci Rep. 2018; 8(1):17354. PMC: 6255833. DOI: 10.1038/s41598-018-35906-2. View

10.

Radhakrishnan K . Challenges in the management of epilepsy in resource-poor countries. Nat Rev Neurol. 2009; 5(6):323-30. DOI: 10.1038/nrneurol.2009.53. View

11.

Hovinga C, Asato M, Manjunath R, Wheless J, Phelps S, Sheth R . Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008; 13(2):316-22. DOI: 10.1016/j.yebeh.2008.03.009. View

12.

Gabr W, Shams M . Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J. 2015; 23(1):33-40. PMC: 4311017. DOI: 10.1016/j.jsps.2014.05.003. View

13.

Kerr M, Scheepers M, Arvio M, Beavis J, Brandt C, Brown S . Consensus guidelines into the management of epilepsy in adults with an intellectual disability. J Intellect Disabil Res. 2009; 53(8):687-94. DOI: 10.1111/j.1365-2788.2009.01182.x. View

14.

Fodjo J, Mandro M, WonyaRossi D, Inac Y, Ngave F, Lokonda R . Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo. EClinicalMedicine. 2019; 9:60-66. PMC: 6510724. DOI: 10.1016/j.eclinm.2019.03.010. View

15.

Kwan P, Arzimanoglou A, Berg A, Brodie M, Hauser W, Mathern G . Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009; 51(6):1069-77. DOI: 10.1111/j.1528-1167.2009.02397.x. View

16.

Bekele F, Gezimu W . Treatment outcome and associated factors among epileptic patients at ambulatory clinic of Mettu Karl Comprehensive Specialized Hospital: A cross-sectional study. SAGE Open Med. 2022; 10:20503121221125149. PMC: 9511297. DOI: 10.1177/20503121221125149. View

17.

Nasir B, Yifru Y, Engidawork E, Gebrewold M, Woldu M, Berha A . Antiepileptic Drug Treatment Outcomes and Seizure-Related Injuries Among Adult Patients with Epilepsy in a Tertiary Care Hospital in Ethiopia. Patient Relat Outcome Meas. 2020; 11:119-127. PMC: 7183344. DOI: 10.2147/PROM.S243867. View

18.

Ndoye N, Sow A, Diop A, Sessouma B, Sene-Diouf F, Boissy L . Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure. 2005; 14(2):106-11. DOI: 10.1016/j.seizure.2004.11.003. View

19.

Brodie M, Barry S, Bamagous G, Norrie J, Kwan P . Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012; 78(20):1548-54. PMC: 3348850. DOI: 10.1212/WNL.0b013e3182563b19. View

20.

Gilad R, Lampl Y, Gabbay U, Eshel Y, Sarova-Pinhas I . Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol. 1996; 53(11):1149-52. DOI: 10.1001/archneur.1996.00550110089017. View